[(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium

C154H211F12N30O9+5 — CID 159112390

About [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium

[(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium (PubChem CID 159112390) has the molecular formula C154H211F12N30O9+5 and a molecular weight of 2854.56 g/mol. Its IUPAC name is [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium.

Molecular Properties

• Compound Name: [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium
• PubChem CID: 159112390
• Molecular Formula: C154H211F12N30O9+5
• Molecular Weight: 2854.56 g/mol
• Exact Mass: 2852.68
• IUPAC Name: [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium
• SMILES: C[C@@H](CC(=O)[C@@H](N)CCC[N+](C)(CCN)CCN)C(=O)N[C@H](CCc1cnc2ccccc2c1)Cc1ccc(C(F)(F)F)cc1.C[N+](CCN)(CCN)CCC[C@H](N)C(=O)NC1(C(=O)Cc2cnc3ccccc3c2)Cc2ccccc2C1.C[N+](CCN)(CCN)CCC[C@H](N)C(=O)N[C@@H](Cc1ccc(C(F)(F)F)cc1)c1nc(Cc2ccccc2)co1.C[N+](CCN)(CCN)CCC[C@H](N)C(=O)N[C@H](CCc1cnc2ccccc2c1)Cc1ccc(C(F)(F)F)cc1.NCC[N+]1(CCN)CCC([C@H](N)C(=O)N[C@@H](Cc2ccc(C(F)(F)F)cc2)C(=O)Cc2cnc3ccccc3c2)CC1
• InChI: InChI=1S/C34H47F3N6O2.C31H39F3N6O2.C30H41F3N6O.C30H40N6O2.C29H39F3N6O2/c1-24(20-32(44)30(40)7-5-17-43(2,18-15-38)19-16-39)33(45)42-29(22-25-9-12-28(13-10-25)34(35,36)37)14-11-26-21-27-6-3-4-8-31(27)41-23-26;32-31(33,34)25-7-5-21(6-8-25)18-27(28(41)19-22-17-24-3-1-2-4-26(24)38-20-22)39-30(42)29(37)23-9-13-40(14-10-23,15-11-35)16-12-36;1-39(17-14-34,18-15-35)16-4-6-27(36)29(40)38-26(20-22-8-11-25(12-9-22)30(31,32)33)13-10-23-19-24-5-2-3-7-28(24)37-21-23;1-36(15-12-31,16-13-32)14-6-10-26(33)29(38)35-30(19-24-8-2-3-9-25(24)20-30)28(37)18-22-17-23-7-4-5-11-27(23)34-21-22;1-38(16-13-33,17-14-34)15-5-8-25(35)27(39)37-26(19-22-9-11-23(12-10-22)29(30,31)32)28-36-24(20-40-28)18-21-6-3-2-4-7-21/h3-4,6,8-10,12-13,21,23-24,29-30H,5,7,11,14-20,22,38-40H2,1-2H3;1-8,17,20,23,27,29H,9-16,18-19,35-37H2;2-3,5,7-9,11-12,19,21,26-27H,4,6,10,13-18,20,34-36H2,1H3;2-5,7-9,11,17,21,26H,6,10,12-16,18-20,31-33H2,1H3;2-4,6-7,9-12,20,25-26H,5,8,13-19,33-35H2,1H3/p+5/t24-,29+,30-;27-,29-;26-,27+;26-;25-,26-/m00100/s1
• InChIKey: KEQVJXUESYSJOC-IXIDQHPGSA-S
• XLogP: 14.56
• TPSA: 664.60 Ų
• H-Bond Donors: 20
• H-Bond Acceptors: 29
• Rotatable Bonds: 73
• Heavy Atoms: 205
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2854.56
LogP ≤ 5	14.56
H-Bond Donors ≤ 5	20
H-Bond Acceptors ≤ 10	29

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium?

The IUPAC name of [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium (CID 159112390) is [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium.

What is the SMILES notation for [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium?

The canonical SMILES for [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium is C[C@@H](CC(=O)[C@@H](N)CCC[N+](C)(CCN)CCN)C(=O)N[C@H](CCc1cnc2ccccc2c1)Cc1ccc(C(F)(F)F)cc1.C[N+](CCN)(CCN)CCC[C@H](N)C(=O)NC1(C(=O)Cc2cnc3ccccc3c2)Cc2ccccc2C1.C[N+](CCN)(CCN)CCC[C@H](N)C(=O)N[C@@H](Cc1ccc(C(F)(F)F)cc1)c1nc(Cc2ccccc2)co1.C[N+](CCN)(CCN)CCC[C@H](N)C(=O)N[C@H](CCc1cnc2ccccc2c1)Cc1ccc(C(F)(F)F)cc1.NCC[N+]1(CCN)CCC([C@H](N)C(=O)N[C@@H](Cc2ccc(C(F)(F)F)cc2)C(=O)Cc2cnc3ccccc3c2)CC1.

What is the InChIKey of [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium?

The InChIKey is KEQVJXUESYSJOC-IXIDQHPGSA-S. The full InChI is InChI=1S/C34H47F3N6O2.C31H39F3N6O2.C30H41F3N6O.C30H40N6O2.C29H39F3N6O2/c1-24(20-32(44)30(40)7-5-17-43(2,18-15-38)19-16-39)33(45)42-29(22-25-9-12-28(13-10-25)34(35,36)37)14-11-26-21-27-6-3-4-8-31(27)41-23-26;32-31(33,34)25-7-5-21(6-8-25)18-27(28(41)19-22-17-24-3-1-2-4-26(24)38-20-22)39-30(42)29(37)23-9-13-40(14-10-23,15-11-35)16-12-36;1-39(17-14-34,18-15-35)16-4-6-27(36)29(40)38-26(20-22-8-11-25(12-9-22)30(31,32)33)13-10-23-19-24-5-2-3-7-28(24)37-21-23;1-36(15-12-31,16-13-32)14-6-10-26(33)29(38)35-30(19-24-8-2-3-9-25(24)20-30)28(37)18-22-17-23-7-4-5-11-27(23)34-21-22;1-38(16-13-33,17-14-34)15-5-8-25(35)27(39)37-26(19-22-9-11-23(12-10-22)29(30,31)32)28-36-24(20-40-28)18-21-6-3-2-4-7-21/h3-4,6,8-10,12-13,21,23-24,29-30H,5,7,11,14-20,22,38-40H2,1-2H3;1-8,17,20,23,27,29H,9-16,18-19,35-37H2;2-3,5,7-9,11-12,19,21,26-27H,4,6,10,13-18,20,34-36H2,1H3;2-5,7-9,11,17,21,26H,6,10,12-16,18-20,31-33H2,1H3;2-4,6-7,9-12,20,25-26H,5,8,13-19,33-35H2,1H3/p+5/t24-,29+,30-;27-,29-;26-,27+;26-;25-,26-/m00100/s1.

What are the key properties of [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium?

[(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium has a molecular weight of 2854.56 g/mol, XLogP of 14.56, 73 rotatable bonds, 20 hydrogen bond donors, and 29 hydrogen bond acceptors.

Where does this data come from?

All data for [(4S)-4-amino-5-[[(1S)-1-(4-benzyl-1,3-oxazol-2-yl)-2-[4-(trifluoromethyl)phenyl]ethyl]amino]-5-oxopentyl]-bis(2-aminoethyl)-methylazanium;(2S)-2-amino-2-[1,1-bis(2-aminoethyl)piperidin-1-ium-4-yl]-N-[(2S)-3-oxo-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]acetamide;bis(2-aminoethyl)-[(4S,7S)-4-amino-7-methyl-5,8-dioxo-8-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]octyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[2-(2-quinolin-3-ylacetyl)-1,3-dihydroinden-2-yl]amino]pentyl]-methylazanium;bis(2-aminoethyl)-[(4S)-4-amino-5-oxo-5-[[(2R)-4-quinolin-3-yl-1-[4-(trifluoromethyl)phenyl]butan-2-yl]amino]pentyl]-methylazanium is sourced from PubChem (CID 159112390), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).